Inhibrx Biosciences, Inc. (INBX)
127.95
-0.84
(-0.65%)
USD |
NASDAQ |
May 04, 16:00
126.70
-1.25
(-0.98%)
After-Hours: 20:00
Inhibrx Biosciences Market Cap : 1.869B for May 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 279.37B |
| Boston Scientific Corp. | 84.50B |
| Intuitive Surgical, Inc. | 160.21B |
| Catalyst Pharmaceuticals, Inc. | 3.534B |
| Inovio Pharmaceuticals, Inc. | 78.76M |
Market Cap Related Metrics
| PS Ratio | 1524.25 |
| Price to Book Value | 233.83 |
| Price | 127.95 |
| Earnings Yield | -7.07% |